Home/Filings/4/0001610717-24-000247
4//SEC Filing

Su Zhen 4

Accession 0001610717-24-000247

CIK 0001501989other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 5:36 PM ET

Size

5.3 KB

Accession

0001610717-24-000247

Insider Transaction Report

Form 4
Period: 2024-05-15
Su Zhen
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-05-15+38,00038,000 total
    Exercise: $1.96Exp: 2034-05-14Common Stock (38,000 underlying)
Footnotes (1)
  • [F1]The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Documents

1 file

Issuer

CytomX Therapeutics, Inc.

CIK 0001501989

Entity typeother

Related Parties

1
  • filerCIK 0001991642

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 5:36 PM ET
Size
5.3 KB